The growth hormone receptor (GHR) polymorphism in growth-retarded children with cushing disease: Lack of association with growth and measures of the somatotropic axis

Hormone and Metabolic Research

Volumn 42, Issue 3, 2010, Pages 194-197

  Drori Herishanu, L ^a   Lodish, M ^a   Verma, S ^a   Bimpaki, E ^a   Keil, M F ^a   Horvath, A ^a   Stratakis, C A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cortisol; Cushing syndrome; Genetics; Growth hormone receptor; Pituitary gland

Indexed keywords

GROWTH HORMONE RECEPTOR;

ADOLESCENT; ALLELE; ANTHROPOMETRY; ARTICLE; CHILD; CLINICAL EVALUATION; CORRELATION ANALYSIS; CUSHING DISEASE; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GROWTH HORMONE SECRETING CELL; GROWTH RATE; GROWTH RETARDATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; BODY HEIGHT; BODY MASS INDEX; CHILD; FEMALE; GENETIC ASSOCIATION STUDIES; GROWTH DISORDERS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; PITUITARY ACTH HYPERSECRETION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SOMATOTROPIN;

EID: 77949307935     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1242744     Document Type: Article

References (30)

1. Savage MO, Storr HL, Grossman AB, Krassas GE. Growth and growth hormone secretion in paediatric Cushing's disease. Hormones (Athens, Greece) 2003 2 93-97
2. Voutilainen R, Leisti S, Perheentupa J. Growth in Cushing syndrome. Eur J Pediatr 1985 144 141-145
3. Storr HL, Chan LF, Grossman AB, Savage MO. Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances. Trends Endocrinol Metab 2007 18 167-174
4. Hochberg Z. Mechanisms of steroid impairment of growth. Horm Res 2002 58 (Suppl 1) 33-38
5. Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. J Clin Endocrinol Metab 1994 78 131-137
6. Lichanska AM, Waters MJ. New insights into growth hormone receptor function and clinical implications. Horm Res 2008 69 138-145
7. Buzi F, Mella P, Pilotta A, Prandi E, Lanfranchi F, Carapella T. Growth hormone receptor polymorphisms. Endocr Dev 2007 11 28-35
8. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Gen 2004 36 720-724
9. Binder G, Baur F, Schweizer R, Ranke MB. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab 2006 91 659-664
10. Binder G, Trebar B, Baur F, Schweizer R, Ranke MB. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome. Clin Endocrinol 2008 68 567-572
11. Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold IJ. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 2006 91 1076-1080
12. Pilotta A, Mella P, Filisetti M, Felappi B, Prandi E, Parrinello G, Notarangelo LD, Buzi F. Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children. J Clin Endocrinol Metab 2006 91 1178-1180
13. Carrascosa A, Audi L, Esteban C, Fernandez-Cancio M, Andaluz P, Gussinye M, Clemente M, Yeste D, Albisu MA. Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH Therapy in Short Small-for-Gestational-Age Children. J Clin Endocrinol Metab 2008 93 147-153
14. Carrascosa A, Audi L, Fernandez-Cancio M, Esteban C, Andaluz P, Vilaro E, Clemente M, Yeste D, Albisu MA, Gussinye M. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age. J Clin Endocrinol Metab 2008 93 764-770
15. Blum WF, Machinis K, Shavrikova EP, Keller A, Stobbe H, Pfaeffle RW, Amselem S. The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor. J Clin Endocrinol Metab 2006 91 4171-4174
16. de Graaff LC, Meyer S, Els C, Hokken-Koelega AC. GH receptor d3 polymorphism in Dutch patients with MPHD and IGHD born small or appropriate for gestational age. Clin Endocrinol 2008 68 930-934
17. Carrascosa A, Esteban C, Espadero R, Fernandez-Cancio M, Andaluz P, Clemente M, Audi L, Wollmann H, Fryklund L, Parodi L. The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients. J Clin Endocrinol Metab 2006 91 3281-3286
18. Raz B, Janner M, Petkovic V, Lochmatter D, Eble A, Dattani MT, Hindmarsh PC, Fluck CE, Mullis PE. Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 2008 93 974-980
19. Tauber M, Ester W, Auriol F, Molinas C, Fauvel J, Caliebe J, Nugent T, Fryklund L, Ranke MB, Savage MO, Clark AJ, Johnston LB, Hokken-Koelega AC. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism. Clin Endocrinol 2007 67 457-461
20. Toyoshima MT, Castroneves LA, Costalonga EF, Mendonca BB, Arnhold IJ, Jorge AA. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature. Clin Endocrinol 2007 67 500-504
21. Jensen RB, Vielwerth S, Larsen T, Greisen G, Leffers H, Juul A. The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects. J Clin Endocrinol Metab 2007 92 2758-2763
22. Schreiner F, Stutte S, Bartmann P, Gohlke B, Woelfle J. Association of the growth hormone receptor d3-variant and catch-up growth of preterm infants with birth weight of less than 1500 grams. J Clin Endocrinol Metab 2007 92 4489-4493
23. Mericq V, Roman R, Iniguez G, Angel B, Salazar T, Avila A, Perez-Bravo F, Cassorla F. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children. Horm Res 2007 68 132-138
24. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M, Amselem S. Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 2000 275 18664-18669
25. Adetunji O, Macfarlane I, Javadpour M, Alfirevic A, Pirmohamed M, Blair J. The d3/fl-growth hormone (GH) receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy. Eur J Endocrinol 2009 161 541-546
26. van der Klaauw AA, van der Straaten T, Baak-Pablo R, Biermasz NR, Guchelaar HJ, Pereira AM, Smit JW, Romijn JA. Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults. J Clin Endocrinol Metab 2008 93 2828-2834
27. Schmid C, Krayenbuehl PA, Bernays RL, Zwimpfer C, Maly FE, Wiesli P. Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene. Clinical chemistry 2007 53 1484-1488
28. Mercado M, Gonzalez B, Sandoval C, Esquenazi Y, Mier F, Vargas G, de los Monteros AL, Sosa E. Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly. J Clin Endocrinol Metab 2008 93 3411-3415
29. Bianchi A, Giustina A, Cimino V, Pola R, Angelini F, Pontecorvi A, De Marinis L. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J Clin Endocrinol Metab 2009 94 2015-2022
30. Barbosa EJ, Palming J, Glad CA, Filipsson H, Koranyi J, Bengtsson BA, Carlsson LM, Boguszewski CL, Johannsson G. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency. J Clin Endocrinol Metab 2009 94 639-644